List of insiders holdings for InMed Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ADAMS ERIC A President & CEO | 2024-05-28 16:26:32 | 161,000 0 | 161,000 | Form 4 |
| Cutler Adam D. Director | 2022-01-24 16:17:00 | 95,335 0 | 95,335 | Form 4 |
| WOUDENBERG MICHAEL Chief Operating Officer | 2024-05-28 16:27:14 | 75,100 0 | 75,100 | Form 4 |
| HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 2024-05-28 16:26:47 | 52,000 0 | 52,000 | Form 4 |
| Jagpal Netta Chief Financial Officer | 2024-02-27 15:27:15 | 50,000 0 | 50,000 | Form 3 |
| Johnson Shane Aaron Sr VP & General Manager | 2023-12-26 13:09:48 | 48,000 0 | 48,000 | Form 4 |
| Tegge Jonathan Interim CFO | 2023-12-26 13:08:36 | 31,400 0 | 31,400 | Form 4 |
| Sazdanoff Catherine Director | 2021-12-30 18:03:21 | 29,091 0 | 29,091 | Form 4 |
| Garner William J Director | 2022-01-24 16:19:27 | 16,122 0 | 16,122 | Form 4 |
| COLWILL BRUCE CFO | 2022-01-24 14:02:34 | 11,515 0 | 11,515 | Form 4 |
| HULL ANDREW Director | 2024-03-05 15:20:52 | 8,542 0 | 8,542 | Form 4 |
| Lemerond Nicole Director | 2023-12-26 13:09:25 | 8,500 0 | 8,500 | Form 4 |
| Grove Janet P Director | 2023-12-26 13:08:13 | 8,500 0 | 8,500 | Form 4 |
| Baldasare Bryan T Director | 2023-12-26 13:05:14 | 8,500 0 | 8,500 | Form 4 |
| Li Sarah VP Accounting & Controller | 2022-12-19 17:03:37 | 4,002 0 | 4,002 | Form 4 |
| Edwards Brenda Interim CFO | 2022-04-08 15:07:55 | 0 0 | 0 | Form 3 |
| MANCINI ALEXANDRA DIANE JANET Consultant | 2024-08-02 16:02:46 | 0 0 | 0 | Form 4 |